Age-wise reference range of immature platelet fraction in neonates

V P Krishnan1, Zainab Golwala1, Purva Kanvinde1

  • 1Department of PediatricHaemato-Oncology, Bai Jerbai Wadia Hospital for Children, Mumbai, Maharashtra, India.

Insights

Immature platelet fraction (IPF) reflects bone marrow platelet production. This study establishes new IPF reference ranges for neonates based on gestational age, crucial for diagnosing thrombocytopenia in neonatal intensive care units.

Area of Science:

  • Neonatal Hematology
  • Clinical Pathology
  • Thrombopoiesis

Background:

  • Immature platelet fraction (IPF) quantifies circulating immature platelets, indicating bone marrow thrombopoiesis.
  • Established IPF reference ranges exist for adults, but neonatal values are highly dependent on gestational age.
  • Accurate IPF reference intervals are essential for neonates, particularly those in neonatal intensive care units (NICUs).

Purpose of the Study:

  • To establish reference ranges for IPF in neonates across different corrected gestational age groups.
  • To provide a basis for accurate interpretation of IPF in neonatal clinical practice.

Main Methods:

  • Analysis of complete blood counts (CBC) with IPF from neonates admitted to the NICU.
  • Utilized the Mindray BC-6800 Auto Hematology analyzer for IPF quantification.
  • Neonates were categorized into four groups based on corrected gestational age (CGA): 28-32, 32-34, 34-37, and >37 weeks.
  • IPF reference ranges were derived by calculating mean, standard deviation, and 95% confidence intervals for each group.

Main Results:

  • Mean IPF values for neonates with normal platelet counts were reported for each gestational age group.
  • Term neonates: 3.58 (95% CI 3.29-3.87).
  • Late preterm (34-37 weeks): 4.14 (95% CI 3.82-5.0).
  • Moderate preterm (32-34 weeks): 4.14 (95% CI 3.46-4.82).
  • Very preterm (28-32 weeks): 5.51 (95% CI 3.95-7.07).
  • IPF values showed comparability between hematology analyzers in neonates with normal platelet counts.

Conclusions:

  • This study successfully established reference ranges for IPF in neonates stratified by corrected gestational age.
  • These derived ranges are vital for the accurate assessment of thrombopoiesis and diagnosis of thrombocytopenia in neonates.
  • The findings support the use of IPF analysis in neonatal care for better patient management.

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.4K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
96
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
74
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
76